Sex Differences in Cortical Thickness and Neuropsychiatric Symptom Burden Based on APOE4 Homozygosity in Alzheimer's Disease

被引:1
|
作者
Khoury, Marc A. [1 ,2 ]
Valcic, Mila [1 ]
Churchill, Nathan W. [1 ]
Di Battista, Alex [3 ]
De Luca, Vincenzo [4 ]
Fornazzari, Luis R. [1 ,5 ]
Munoz, David G. [1 ,2 ,6 ]
Fischer, Corinne E. [1 ,2 ,7 ]
Schweizer, Tom A. [1 ,2 ,8 ]
机构
[1] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Temerty Fac Med, Toronto, ON, Canada
[3] Def Res & Dev Canada, Toronto Res Ctr, Toronto, ON, Canada
[4] Ctr Addict & Mental Hlth, Div Geriatr Psychiat, Toronto, ON, Canada
[5] Univ Toronto, Dept Med, Neurol Div, Toronto, ON, Canada
[6] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[7] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada
[8] Univ Toronto, Fac Med, Div Neurosurg, Toronto, ON, Canada
关键词
Alzheimer's disease; APOE4; cortical thickness; neuropsychiatric symptoms; sex differences; APOLIPOPROTEIN-E; BRAIN STRUCTURE; ASSOCIATION; EPSILON-4; GENDER; RISK; AGE; GENOTYPE; DECLINE; ALLELE;
D O I
10.1002/ajmg.b.33008
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Sex differences in patterns of cortical thickness and neuropsychiatric symptom (NPS) burden were examined among individuals with Alzheimer's disease (AD) and two copies (homozygote carriers) of the e4 allele of the apolipoprotein gene (APOE). A total of 752 participants with a clinical etiologic diagnosis of AD were selected from the National Alzheimer's Coordinating Center (NACC) database. Bayesian multilevel regression was used to examine both the within- and between-sex differences in gray-matter cortical thickness and total NPS burden associated with APOE homozygosity. Female homozygote carriers displayed a high probability of having reduced cortical thickness primarily in medial-lateral temporal regions and a greater burden of NPS, relative to both non-homozygous females and homozygous males. These findings support the notion that APOE4 status affects cortical thickness and symptom burden in men and women with AD differentially, with females showing more pronounced effects in brain areas known to be vulnerable in early AD. Future investigations should attempt to elucidate the proposed pattern of decline longitudinally.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology
    Jin, Yunjung
    Li, Fuyao
    Sonoustoun, Berkiye
    Kondru, Naveen Chandra
    Martens, Yuka A.
    Qiao, Wenhui
    Heckman, Michael G.
    Ikezu, Tadafumi C.
    Li, Zonghua
    Burgess, Jeremy D.
    Amerna, Danilyn
    O'Leary, Justin
    DeTure, Michael A.
    Zhao, Jing
    McLean, Pamela J.
    Dickson, Dennis W.
    Ross, Owen A.
    Bu, Guojun
    Zhao, Na
    ACTA NEUROPATHOLOGICA, 2022, 143 (06) : 641 - 662
  • [32] ApoE4: an emerging therapeutic target for Alzheimer's disease
    Safieh, Mirna
    Korczyn, Amos D.
    Michaelson, Daniel M.
    BMC MEDICINE, 2019, 17 (1)
  • [33] mTOR: Alzheimer's disease prevention for APOE4 carriers
    Lin, Ai-Ling
    Butterfield, D. Allan
    Richardson, Arlan
    ONCOTARGET, 2016, 7 (29) : 44873 - 44874
  • [34] ApoE4: an emerging therapeutic target for Alzheimer’s disease
    Mirna Safieh
    Amos D. Korczyn
    Daniel M. Michaelson
    BMC Medicine, 17
  • [35] A hierarchical Bayesian model to predict APOE4 genotype and the age of Alzheimer's disease onset
    Hane, Francis
    Augusta, Carolyn
    Bai, Owen
    PLOS ONE, 2018, 13 (07):
  • [36] APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease
    Fortea, Juan
    Pegueroles, Jordi
    Alcolea, Daniel
    Belbin, Olivia
    Dols-Icardo, Oriol
    Vaque-Alcazar, Lidia
    Videla, Laura
    Gispert, Juan Domingo
    Suarez-Calvet, Marc
    Johnson, Sterling C.
    Sperling, Reisa
    Bejanin, Alexandre
    Lleo, Alberto
    Montal, Victor
    NATURE MEDICINE, 2024, 30 (5) : 1284 - 1291
  • [37] APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease
    Pievani, Michela
    Galluzzi, Samantha
    Thompson, Paul M.
    Rasser, Paul E.
    Bonetti, Matteo
    Frisoni, Giovanni B.
    NEUROIMAGE, 2011, 55 (03) : 909 - 919
  • [38] Functional vitamin E deficiency in ApoE4 patients with Alzheimer's disease
    Mas, E
    Dupuy, AM
    Artero, S
    Portet, F
    Cristol, JP
    Ritchie, K
    Touchon, J
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 21 (03) : 198 - 204
  • [39] Apoe4 and Alzheimer's Disease Pathogenesis-Mitochondrial Deregulation and Targeted Therapeutic Strategies
    Pires, Mariana
    Rego, Ana Cristina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [40] Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease
    Vance, Jeffery M.
    Farrer, Lindsay A.
    Huang, Yadong
    Cruchaga, Carlos
    Hyman, Bradley T.
    Pericak-Vance, Margaret A.
    Goate, Alison M.
    Greicius, Michael D.
    Griswold, Anthony J.
    Haines, Jonathan L.
    Julia, T. C. W.
    Schellenberg, Gerard D.
    Tsai, Li-Huei
    Herz, Joachim
    Holtzman, David M.
    ANNALS OF NEUROLOGY, 2024, 95 (04) : 625 - 634